The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

NCT00719966 ·Status: COMPLETED

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

NCT03351062 ·Status: RECRUITING ·Phase: PHASE3

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

NCT01357772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

NCT00830973 ·Status: COMPLETED

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

NCT00667121 ·Status: COMPLETED

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

NCT00569543 ·Status: COMPLETED

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

NCT00031720 ·Status: COMPLETED ·Phase: PHASE2

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

NCT00253539 ·Status: COMPLETED ·Phase: PHASE2

Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors

NCT01196936 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Tamoxifen in Treating Women With High-Risk Breast Cancer

NCT00002542 ·Status: COMPLETED ·Phase: PHASE3

Tamoxifen in Treating Women With Breast Cancer

NCT00003678 ·Status: UNKNOWN ·Phase: PHASE3

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure

NCT00555477 ·Status: TERMINATED ·Phase: PHASE2

Letrozole After Tamoxifen in Treating Women With Breast Cancer

NCT00003140 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

NCT01814397 ·Status: COMPLETED

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3

Effects of Aromatase Inhibitor Therapy on Muscle Function

NCT03581552 ·Status: COMPLETED

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

NCT01080170 ·Status: COMPLETED

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

NCT03518138 ·Status: COMPLETED ·Phase: PHASE2

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771 ·Status: COMPLETED ·Phase: PHASE4

The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

NCT00171314 ·Status: COMPLETED ·Phase: PHASE3

Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes

NCT00966043 ·Status: COMPLETED

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

NCT00727883 ·Status: COMPLETED

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

NCT00286117 ·Status: COMPLETED ·Phase: PHASE3

Arimidex Observational: Reason for and Effect of Change From Tamoxifen

NCT00246961 ·Status: COMPLETED